Cargando…

Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020–2021 population-based household survey

Population-based serological testing is important to understand the epidemiology and estimate the true cumulative incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to inform public health interventions. This study reports findings of a national household population SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Moyo, Sizulu, Simbayi, Leickness C., Zuma, Khangelani, Zungu, Nompumelelo, Marinda, Edmore, Jooste, Sean, Ramlagan, Shandir, Fortuin, Mirriam, Singh, Beverley, Mabaso, Musawenkosi, Reddy, Tarylee, Parker, Whadi-ah, Naidoo, Inbarani, Manda, Samuel, Goga, Ameena, Ngandu, Nobubelo, Cawood, Cherie, Moore, Penny L., Puren, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519586/
https://www.ncbi.nlm.nih.gov/pubmed/37747851
http://dx.doi.org/10.1371/journal.pgph.0002358
_version_ 1785109732252450816
author Moyo, Sizulu
Simbayi, Leickness C.
Zuma, Khangelani
Zungu, Nompumelelo
Marinda, Edmore
Jooste, Sean
Ramlagan, Shandir
Fortuin, Mirriam
Singh, Beverley
Mabaso, Musawenkosi
Reddy, Tarylee
Parker, Whadi-ah
Naidoo, Inbarani
Manda, Samuel
Goga, Ameena
Ngandu, Nobubelo
Cawood, Cherie
Moore, Penny L.
Puren, Adrian
author_facet Moyo, Sizulu
Simbayi, Leickness C.
Zuma, Khangelani
Zungu, Nompumelelo
Marinda, Edmore
Jooste, Sean
Ramlagan, Shandir
Fortuin, Mirriam
Singh, Beverley
Mabaso, Musawenkosi
Reddy, Tarylee
Parker, Whadi-ah
Naidoo, Inbarani
Manda, Samuel
Goga, Ameena
Ngandu, Nobubelo
Cawood, Cherie
Moore, Penny L.
Puren, Adrian
author_sort Moyo, Sizulu
collection PubMed
description Population-based serological testing is important to understand the epidemiology and estimate the true cumulative incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to inform public health interventions. This study reports findings of a national household population SARS-CoV-2 serosurvey in people 12 years and older in South Africa. This cross-sectional multi-stage random stratified cluster survey undertaken from November 2020 to June 2021 collected sociodemographic data, medical history, behavioural data, and blood samples from consenting participants. The samples were tested for SARS-CoV-2 antibodies using the Roche ElecsysAnti-SARS-CoV-2 chemiluminescence immunoassay (CLIA) Total Antibody Test. The survey data were weighted by age, race, sex, and province with final individual weights benchmarked against the 2020 mid-year population estimates and accounted for clustering. Descriptive statistics summarize the characteristics of participants and seroprevalence. Logistic regression analyses were used to identify factors associated with seropositivity. From 13290 survey participants (median age 33 years, interquartile range (IQR) 23–46 years), SARS-CoV-2 seroprevalence was 37.8% [95% Confidence Interval (CI) 35.4–40.4] and varied substantially across the country’s nine provinces, and by sex, age and locality type. In the final adjusted model, the odds of seropositivity were higher in women than in men [aOR = 1.3 (95% CI: 1.0–1.6), p = 0.027], and those living with HIV (self-report) [aOR = 1.6 (95% CI: 1.0–2.4), p = 0.031]. The odds were lower among those 50 years and older compared to adolescents 12–19 years old [aOR = 0.6 (95% CI: 0.5–0.8), p<0.001] and in those who did not attend events or gatherings [aOR = 0.7 (95% CI: 0.6–1.0), p = 0.020]. The findings help us understand the epidemiology of SARS-CoV-2 within different regions in a low-middle-income country. The survey highlights the higher risk of infection in women in South Africa likely driven by their home and workplace roles and also highlighted a need to actively target and include younger people in the COVID-19 response.
format Online
Article
Text
id pubmed-10519586
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-105195862023-09-26 Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020–2021 population-based household survey Moyo, Sizulu Simbayi, Leickness C. Zuma, Khangelani Zungu, Nompumelelo Marinda, Edmore Jooste, Sean Ramlagan, Shandir Fortuin, Mirriam Singh, Beverley Mabaso, Musawenkosi Reddy, Tarylee Parker, Whadi-ah Naidoo, Inbarani Manda, Samuel Goga, Ameena Ngandu, Nobubelo Cawood, Cherie Moore, Penny L. Puren, Adrian PLOS Glob Public Health Research Article Population-based serological testing is important to understand the epidemiology and estimate the true cumulative incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to inform public health interventions. This study reports findings of a national household population SARS-CoV-2 serosurvey in people 12 years and older in South Africa. This cross-sectional multi-stage random stratified cluster survey undertaken from November 2020 to June 2021 collected sociodemographic data, medical history, behavioural data, and blood samples from consenting participants. The samples were tested for SARS-CoV-2 antibodies using the Roche ElecsysAnti-SARS-CoV-2 chemiluminescence immunoassay (CLIA) Total Antibody Test. The survey data were weighted by age, race, sex, and province with final individual weights benchmarked against the 2020 mid-year population estimates and accounted for clustering. Descriptive statistics summarize the characteristics of participants and seroprevalence. Logistic regression analyses were used to identify factors associated with seropositivity. From 13290 survey participants (median age 33 years, interquartile range (IQR) 23–46 years), SARS-CoV-2 seroprevalence was 37.8% [95% Confidence Interval (CI) 35.4–40.4] and varied substantially across the country’s nine provinces, and by sex, age and locality type. In the final adjusted model, the odds of seropositivity were higher in women than in men [aOR = 1.3 (95% CI: 1.0–1.6), p = 0.027], and those living with HIV (self-report) [aOR = 1.6 (95% CI: 1.0–2.4), p = 0.031]. The odds were lower among those 50 years and older compared to adolescents 12–19 years old [aOR = 0.6 (95% CI: 0.5–0.8), p<0.001] and in those who did not attend events or gatherings [aOR = 0.7 (95% CI: 0.6–1.0), p = 0.020]. The findings help us understand the epidemiology of SARS-CoV-2 within different regions in a low-middle-income country. The survey highlights the higher risk of infection in women in South Africa likely driven by their home and workplace roles and also highlighted a need to actively target and include younger people in the COVID-19 response. Public Library of Science 2023-09-25 /pmc/articles/PMC10519586/ /pubmed/37747851 http://dx.doi.org/10.1371/journal.pgph.0002358 Text en © 2023 Moyo et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Moyo, Sizulu
Simbayi, Leickness C.
Zuma, Khangelani
Zungu, Nompumelelo
Marinda, Edmore
Jooste, Sean
Ramlagan, Shandir
Fortuin, Mirriam
Singh, Beverley
Mabaso, Musawenkosi
Reddy, Tarylee
Parker, Whadi-ah
Naidoo, Inbarani
Manda, Samuel
Goga, Ameena
Ngandu, Nobubelo
Cawood, Cherie
Moore, Penny L.
Puren, Adrian
Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020–2021 population-based household survey
title Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020–2021 population-based household survey
title_full Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020–2021 population-based household survey
title_fullStr Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020–2021 population-based household survey
title_full_unstemmed Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020–2021 population-based household survey
title_short Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020–2021 population-based household survey
title_sort seroprevalence survey of anti-sars-cov-2 antibody and associated factors in south africa: findings of the 2020–2021 population-based household survey
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519586/
https://www.ncbi.nlm.nih.gov/pubmed/37747851
http://dx.doi.org/10.1371/journal.pgph.0002358
work_keys_str_mv AT moyosizulu seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT simbayileicknessc seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT zumakhangelani seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT zungunompumelelo seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT marindaedmore seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT joostesean seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT ramlaganshandir seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT fortuinmirriam seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT singhbeverley seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT mabasomusawenkosi seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT reddytarylee seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT parkerwhadiah seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT naidooinbarani seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT mandasamuel seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT gogaameena seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT ngandunobubelo seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT cawoodcherie seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT moorepennyl seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey
AT purenadrian seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey